Federated Hermes, Inc. Biocryst Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 298,201 shares of BCRX stock, worth $2.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

298,201

Previous 184,904 61.27%

Holding current value

$2.17 Million

Previous $1.39 Million 92.71%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.41 - $11.19 $726,233 - $1.27 Million	113,297 Added 61.27%	298,201 $2.67 Million
Q1 2025 May 08, 2025	BUY	$7.06 - $9.39 $119,645 - $159,132	16,947 Added 10.09%	184,904 $1.39 Million
Q4 2024 Feb 13, 2025	BUY	$7.03 - $8.43 $400,217 - $479,919	56,930 Added 51.28%	167,957 $1.26 Million
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $711,683 - $964,824	111,027 New	111,027 $843,000
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $2,745 - $6,222	-348 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $553,643 - $946,365	-47,893 Reduced 99.28%	348 $6,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $9.17 Million - $12.7 Million	-819,896 Reduced 94.44%	48,241 $668,000
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $1.72 Million - $2.14 Million	121,166 Added 16.22%	868,137 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $6.86 Million - $12.4 Million	722,057 Added 2898.2%	746,971 $11.8 Million
Q1 2021 May 13, 2021	BUY	$7.37 - $13.61 $182,407 - $336,847	24,750 Added 15091.46%	24,914 $253,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $552 - $1,412	164 New	164 $1,000
Q4 2019 Feb 14, 2020	SELL	$1.59 - $3.45 $526,563 - $1.14 Million	-331,172 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $692,860 - $1.03 Million	-277,144 Reduced 45.56%	331,172 $949,000
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $497,871 - $1.57 Million	-171,090 Reduced 21.95%	608,316 $2.31 Million
Q1 2019 May 10, 2019	BUY	$7.38 - $9.72 $2.53 Million - $3.34 Million	343,269 Added 78.71%	779,406 $6.34 Million
Q4 2018 Feb 13, 2019	BUY	$6.51 - $9.6 $2.83 Million - $4.17 Million	434,756 Added 31481.25%	436,137 $3.52 Million
Q3 2018 Nov 13, 2018	BUY	$5.52 - $7.99 $7,623 - $11,034	1,381 New	1,381 $11,000

Others Institutions Holding BCRX

# of Institutions

315

Shares Held

201M

Call Options Held

930K

Put Options Held

553K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.35B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Biocryst Pharmaceuticals Inc Transaction History